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Flu W.-J., Schouten O., van Kuijk J.-P., Poldermans D. Eur J Vasc Endovasc
Surg 2010;40:1–8.
Background: Patients undergoing vascular surgery are at increased risk
for developing cardiac complications. Majority of patients with perioperative
myocardial damage are asymptomatic. Our objective is to review the avail-
able literature addressing the prevalence and prognostic implications of
perioperative myocardial damage in vascular surgery patients.
Methods: An Internet-based literature search was performed using
MEDLINE to identify all published reports on perioperative myocardial
damage in vascular surgery patients. Only those studies published from 2000
to 2010 evaluating myocardial damage using troponin I or T, with or
without symptoms of angina pectoris were included.
Results: Thirteen studies evaluating the prevalence of perioperative
myocardial ischaemia or infarction were included in the study. The incidence
of perioperative myocardial ischaemia ranged from 14% to 47% and the
incidence of perioperative myocardial infarction ranged from 1% to 26%. In
addition, 10 studies evaluating the prognostic value of perioperative myo-
cardial ischaemia towards postoperative mortality or the occurrence of major
adverse cardiac events were included. In the retrieved studies, hazard ratios
varied from 1.9 to 9.0.
Conclusion: The high prevalence and asymptomatic nature of periop-
erative myocardial damage, combined with a substantial influence on post-
operative mortality of vascular surgery patients, underline the importance of
early detection and adequate management of perioperative myocardial dam-
age.
This article provides an extended overview regarding the prevalence
and prognostic value of perioperative myocardial ischaemia and infarction in
vascular surgery patients. In addition, treatment options to reduce the risk of
perioperative myocardial damage are provided based on the current available
literature.
Changing Profiles of Diagnostic and Treatment Options in Subclavian
Artery Aneurysms
Vierhout B.P., Zeebregts C.J., van den Dungen J.J.A.M., Reijnen M.M.P.J.
Eur J Vasc Endovasc Surg 2010;40:27–34.
Background: Subclavian artery aneurysms (SAAs) are rare and may
cause life- and limb-threatening complications. Therapeutic options greatly
differ as do access alternatives. The aim of the study was to assess its clinical
presentation, diagnostics and therapeutic options as reported in the litera-
ture.
Method: A literature search was performed of the Medline, Cochrane
and EMBASE databases. All articles, published until September 2009,
describing treatment of an SAA were included.
Results: A total of 191 reports, of which 126 met the inclusion criteria,
were identified and were published from June 1915 until September 2009.
Of these, 394 SAAs were described in 381 patients, with a mean age of
52  16 years. The median diameter was 40 mm (range: 10–180 mm). The
aetiology appeared to change in time towards more exogenous causes.
Fifty-one percent of the SAAs presented with a pulsating mass, shoulder pain
and/or non-specific chest pain. Embolisation, rupture and thrombosis were
present in 16%, 9% and 6% of patients, respectively, and their incidence was
related to the anatomical localisation of the SAA. Open surgery and endo-
vascular repair had a complication rate of 26% and 28%, respectively
(p  0.49). Cardiopulmonary complications were restricted to open re-
pair. Mortality rates for open and endovascular techniques were similar
(5%). The mortality rates for conventional elective and emergency pro-
cedures were 3% and 13%, respectively, and for endovascular repair 4%
and 8%, respectively.
Conclusion: The profiles of diagnostic and treatment options of SAAs
are changing. Although guidelines considering timing of intervention may
not be conducted from available literature, intervention appears to be
indicated, especially in distal SAAs, due to the risk of thrombo-embolic
complications. Endovascular repair and hybrid procedures appear to be the
preferred treatment modalities, due to a lower rate of cardiopulmonary
complications.Percutaneous Endovascular Treatment of Innominate Artery Lesions:
A Single-centre Experience on 77 lesions
Paukovits T.M., Lukács L., Bérczi V., Hirschberg K., Nemes B., Hüttl K.
Eur J Vasc Endovasc Surg 2010;40:35–43.
Purpose: To assess primary success and safety of percutaneous trans-
luminal angioplasty and/or stenting of innominate artery lesions and to
compare its 30-day stroke/mortality level with the literature data.
Methods: A total of 72 patients (77 stenoses, five recurrent, 58
symptomatic and 39 female) with seven innominate vessel occlusions, nine
subocclusive lesions and 61 significant (60%) stenoses of innominate artery
treated between 2000 and 2009 were retrospectively reviewed. With the
exception of seven, all procedures were performed using a transfemoral
approach. A stent was implanted in 49 (63.6%) cases. Follow-up included
neurological examination, carotid duplex scan and office/telephone inter-
view.
Results: Primary technical success was 93.5% (72/77). There was
neither periprocedural (48 h) death, nor major neurological complication.
Minor periprocedural neurological complications consisted of 2/72 (2.6%)
ipsilateral TIAs. Access site complications included 4 (5.2%) access site
bleedings. Follow-up was achieved in 65/72 (90.3%) of all patients and 68
(88.3%) of all procedures for a mean of 42.3 months and revealed neither
major neurological complication, nor additional TIA.
The cumulative primary patency rate was 100% at 12 months,
98  1.6% at 24 months, and 69.9  8.5% at 96 months. The cumulative
secondary patency rate was 100% at 12 and at 24 months, and 81.5  7.7%
at 96 months. Log-rank test showed no significant difference (p  0.79) in
primary cumulative patencies between PTA alone (n  28) or PTA/stent
(n  49).
Conclusion: Transfemoral PTA with or without stent appears to be a
safe treatment option for innominate artery lesions.
Predicting Patient-Specific Expansion of Abdominal Aortic Aneurysms
Helderman F., Manoch I.J., Breeuwer M., Kose U., Boersma H., van
Sambeek M.R.H.M., Pattynama P.M.T., Schouten O., Poldermans D.,
Wisselink W., van der Steen A.F.W., Krams R. Eur J Vasc Endovasc Surg
2010;40:47–53.
Objective: Local anatomy and the patient’s risk profile independently
affect the expansion rate of an abdominal aortic aneurysm. We describe a
hybrid method that combines finite element modelling and statistical meth-
ods to predict patient-specific aneurysm expansion.
Methods: The 3-D geometry of the aneurysm was imaged with com-
puted tomography. We used finite element methods to calculate wall stress
and aneurysm expansion. Expansion rate was adjusted by risk factors ob-
tained from a database of 80 patients. Aneurysm diameters predicted with
and without the risk profiles were compared with diameters measured with
ultrasound for 11 patients.
Results: For this specific group of patients, local anatomy contributed
62% and the risk profile 38% to the aneurysmal expansion rate. Predictions
with risk profiles resulted in smaller root mean square errors than predictions
without risk profiles (2.9 vs. 4.0 mm, p  0.01).
Conclusions: This hybrid approach predicted aneurysmal expansion
for a period of 30 months with high accuracy.
Early Results After Treatment of Open Abdomen After Aortic Surgery
With Mesh Traction and Vacuum-Assisted Wound Closure
Seternes A., Myhre H.O., Dahl T. Eur J Vasc Endovasc Surg 2010;40:
60–64.
Objectives: This study aimed to describe the use of vacuum-assisted
wound closure (VAWC) and mesh traction to repair an open abdomen after
aortic surgery.
Design: Prospective clinical study.
Material and methods: From October 2006 to April 2009, nine
consecutive patients were treated; seven of the patients received laparostomy
following abdominal compartment syndrome (ACS), while two wounds
were left open initially. The indication for laparostomy was intra-abdominal
pressure (IAP)  20 mmHg or abdominal perfusion pressure (APP)  60
mmHg and development of organ failure. V.A.C. therapy (KCI, San Anto-
nio, TX, USA) was initiated with the laparostomy, and supplemented with a
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